[Bulevirtide (chronic hepatitis D, children >= 3 to < 18 years, >= 10 kg) – assessment according to §35a (para. 1, sentence 11) Social Code Book V]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018014005
German
Original Title: Bulevirtid (chronische Hepatitis D bei Kindern und Jugendlichen)
Details
Project Status: Completed
URL for project: https://www.iqwig.de/projekte/g25-02.html
Year Published: 2025
URL for published report: https://www.iqwig.de/download/g25-02_bulevirtid_bewertung-35a-absatz-1-satz-11-sgb-v_v1-0_final.pdf
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
DOI: https://doi.org/10.60584/G25-02
MeSH Terms
  • Hepatitis D, Chronic
  • Child
  • Adolescent
  • Lipopeptides
  • Antiviral Agents
  • Hepatitis Delta Virus
Keywords
  • Bulevirtide
  • Hepatitis D – Chronic
  • Child
  • Adolescent
  • Health Care Costs
  • Epidemiology
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.